Icelandic teenager shares transformative experience with weight management medications

In Iceland, approximately 50 children are currently using weight management medications, with one 18-year-old boy crediting these drugs for significantly improving his life. After beginning treatment at 16, Sveinn Rúnar Sveinsson faced a dire reality when his doctor indicated he might not reach adulthood due to severe weight issues.

Weighing as much as 140 kilograms at 16, Sveinn had always been active, engaged in handball, but struggled with a metabolic condition called PKU which impacted his diet. Having faced bullying because of his weight, he began using Saxenda, and recently transitioned to Wegovy, which he found transformative despite experiencing initial side effects like dizziness and nausea.

Sveinn emphasizes the necessity of a mental shift alongside medication. He committed to improving his diet and fully engaging in sports, which fostered a positive outlook. Importantly, he has not faced bullying from peers since starting the treatment.

His father, Sveinn Hjörtur Guðfinnsson, stresses the need for societal discussions around obesity, advocating for recognition of it as a medical condition that requires appropriate governmental response, similar to diabetes treatment. Both father and son encourage open conversations about weight issues, breaking the stigma around seeking help.

However, high medication costs pose a challenge for families without insurance coverage, risking unauthorized use of these drugs due to affordability concerns. The Icelandic Directorate of Health aims to enhance understanding of obesity while expanding treatment options, underscoring the importance of education in combating this health crisis.